EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



ChemMedChem

Description
Chemistry Enabling Drug Discovery

 

Status
active
Indexing
Biological Abstracts® (Thomson ISI); BIOSIS Previews® (Thomson ISI); Chemical Abstracts Service/SciFinder (ACS); ChemInform (Wiley-VCH/FIZ Chemie); COMPENDEX (Elsevier); Current Contents®/Life Sciences (Thomson ISI); EMBASE/Excerpta Medica (Elsevier); EMNursing (Elsevier); GEOBASE/Geographical & Geological Abstracts (Elsevier); Index Medicus/MEDLINE; PubMed (NLM); International Pharmaceutical Abstracts (Thomson Scientific); Mosby Yearbooks (Elsevier); Science Citation Index® (Thomson ISI);
SCOPUS (Elsevier); Web of Science® (Thomson ISI)
Subject

Source type
Journal
Publisher
ISBN ISSN
1860-7179
E ISSN
1860-7187
First volume
1
Last volume
4+
Publish city
Weinheim
Homepage
Description

With its first impact factor of 2.825 (2007), ChemMedChem on its way to become a premier journal at the interface of chemistry, biology and medicine. ChemMedChem is made in Europe, but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies—to name just a few topics.

ChemMedChem replaces Il Farmaco—An International Journal of Medicinal Chemistry and Pharmaceutical Chemistry, which was published by the Società Chimica Italiana until the end of 2005 and generously given up in order to limit the crowding of journals in these sciences.



Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )